G. Urbonas

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
G Urbonas, G. Urbonas, Gediminas Urbonas
Publication record
22 papers · 2,706 citations · H-index 6

PAPERS

Low-Density Lipoprotein Cholesterol Target Attainment in Lithuania: A Nationwide Analysis of Real-World Health Data
20250 citationsauthor #1
Prevalence of Cardiovascular–Kidney–Metabolic (CKM) Syndrome in Lithuanian Adults: Insights from a Nationwide Real-World Study Using Electronic Health Records
20250 citationsauthor #1
SAT-008 Population-based hepatitis C screening and elimination program in Lithuania: 26-month results
20250 citationsauthor #4
Five-Year Trends in Low-Density Lipoprotein Cholesterol Management in a Primary Healthcare Centre in Kaunas
20241 citationsauthor #1
Hepatitis C screening in Lithuania: first-year results and scenarios for achieving WHO elimination targets
20243 citationsauthor #9
WED-474 Population-based hepatitis C screening in Lithuania: 18-month results of the program and scenarios for achieving WHO elimination targets
20240 citationsauthor #10
Hepatitis C screening program in Lithuania: first results and scenarios for virus elimination
20231 citationsauthor #4
Validation of the Lithuanian multimorbidity treatment burden questionnaire (MTBQ) and its association with primary care patient characteristics
20236 citationsauthor #7
Evaluation of Satisfaction with Healthcare Services in Multimorbid Patients Using PACIC+ Questionnaire: A Cross-Sectional Study
20232 citationsauthor #1
EE166 Cost-Effectiveness of the Pneumococcal Conjugate Vaccine 10 Versus 13 on Pneumococcal Disease in Children in Sweden
20220 citationsauthor #8
Hepatitis C Virus Epidemiology in Lithuania: Situation before Introduction of the National Screening Programme
20226 citationsauthor #8
Assessing the Pilot Implementation of the Integrated Multimorbidity Care Model in Five European Settings: Results from the Joint Action CHRODIS-PLUS
202015 citationsauthor #21
Primary Prevention of Cardiovascular Risk in Lithuania—Results from EUROASPIRE V Survey
20202 citationsauthor #1
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
2019460 citationsauthor #768
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
20192,141 citationsauthor #768
The Quality of Anticoagulation Therapy among Warfarin-Treated Patients with Atrial Fibrillation in a Primary Health Care Setting
201927 citationsauthor #1
Long‐term safety and efficacy of acotiamide in functional dyspepsia (postprandial distress syndrome)—results from the European phase 3 open‐label safety trial
201847 citationsauthor #3
Su1628 - Long-Term Safety and Efficacy of Acotiamide in Patients with Functional Dyspepsia (Postprandial Distress Syndrome) — Results from the European Phase 3 Trial
20180 citationsauthor #3
Dependency Of Warfarin Therapy Efficiency Among Patients With Chronic Atrial Fibrillation On The Distance To Medical Institution
20172 citationsauthor #1
Readiness for Interprofessional Collaboration : Attitudes of Lithuanian Community Nurses and Family Physicians
20161 citationsauthor #7
Contraction force versus action potential duration of cardiomyocytes: which methodology is more informative for selection of effective 1,4-dihydropyridine compounds in experimental research?
20150 citationsauthor #3
Disobedience: An Ongoing Video Archive
20130 citationsauthor #2

TIMELINE

2013 0 citations

2015 0 citations

2016 1 citations

2017 2 citations

2018 47 citations

2019 2,628 citations

2020 17 citations

2022 6 citations

2023 9 citations

2024 4 citations

2025 0 citations

G. Urbonas

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT